Operating Metrics 營運指標
AstraZeneca PLC (AZN) Operating Metrics 營運指標
AstraZeneca PLC AZN 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-30
最新營運指標
- Oncology Revenue
- $27,789M · 2026-06-30 來源：AstraZeneca、AstraZeneca、AstraZeneca、AstraZeneca
- CVRM Revenue
- $12,361M · 2026-06-30 來源：AstraZeneca、AstraZeneca、AstraZeneca、AstraZeneca
- Respiratory & Immunology Revenue
- $9,381M · 2026-06-30 來源：AstraZeneca、AstraZeneca、AstraZeneca、AstraZeneca
- Rare Disease Revenue
- $9,700M · 2026-06-30 來源：AstraZeneca、AstraZeneca、AstraZeneca、AstraZeneca
- Tagrisso Product Revenue
- $7,540M · 2026-06-30 來源：AstraZeneca、AstraZeneca、AstraZeneca、AstraZeneca
- Imfinzi Product Revenue
- $6,896M · 2026-06-30 來源：AstraZeneca、AstraZeneca、AstraZeneca、AstraZeneca
- Tagrisso Total Revenue (Legacy)
- $1,703M · 2024-12-31 來源：AstraZeneca
- Imfinzi Total Revenue (Legacy)
- $1,254M · 2024-12-31 來源：AstraZeneca
季度趨勢
| 指標 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Oncology Revenue | $7,327M | $6,798M | $7,028M | $6,636M | $6,312M | $5,643M | $6,344M | $5,569M |
| CVRM Revenue | $2,772M | $3,317M | $3,051M | $3,221M | $3,266M | $3,322M | $3,138M | $3,159M |
| Respiratory & Immunology Revenue | $2,431M | $2,318M | $2,373M | $2,259M | $2,150M | $2,084M | $2,127M | $1,959M |
| Rare Disease Revenue | $2,490M | $2,420M | $2,374M | $2,416M | $2,294M | $2,042M | $2,377M | $2,148M |
| Tagrisso Product Revenue | $1,941M | $1,833M | $1,902M | $1,864M | $1,810M | $1,679M | — | — |
| Imfinzi Product Revenue | $1,854M | $1,694M | $1,747M | $1,601M | $1,455M | $1,261M | — | — |
| Tagrisso Total Revenue (Legacy) | — | — | — | — | — | — | $1,703M | $1,674M |
| Imfinzi Total Revenue (Legacy) | — | — | — | — | — | — | $1,254M | $1,203M |
資料來源
- H1 and Q2 2026 results announcement · AstraZeneca · 2026-07-27
- Q1 2026 results announcement · AstraZeneca · 2026-04-29
- Full-year and Q4 2025 results announcement · AstraZeneca · 2026-02-10
- 9M and Q3 2025 results announcement · AstraZeneca · 2025-11-06
- H1 and Q2 2025 results announcement · AstraZeneca · 2025-07-29
- Q1 2025 results announcement · AstraZeneca · 2025-04-29
- Full-year and Q4 2024 results announcement · AstraZeneca · 2025-02-06
- 9M and Q3 2024 results announcement · AstraZeneca · 2024-11-12